Safety and efficacy of ciprofol for the sedation/anesthesia in pediatric gastroscopy

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300072725

Enrollment

Unknown

Registered

2023-06-22

Start date

2023-06-15

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

C1 Group:Ciprofol (0.4mg/kg) was given for induction and maintenance of anesthesia

C2 Group:Ciprofol (0.6mg/kg) was given for induction and maintenance of anesthesia

P Group:Propofol (1.5mg/kg) was given for induction and maintenance of anesthesia

Eligibility

Sex/Gender

All

Age

3 Years to 14 Years

Inclusion criteria

Inclusion criteria: 1) ASA?~? grade 2) Children who plan to receive elective tracheoscopy 3) Age range from 1 to 10 years 4) BMI18~28kg/m2.

Exclusion criteria

Exclusion criteria: 1) Patients with a history of anaesthetic drug allergy 2) Congenital heart disease (tetralogy of Fallot, patent ductus arteriosus, ventricular septal defect, pulmonary hypertension) 3) People with severe neurological and mental diseases and cognitive dysfunction 4) Patients with perioperative experience of general anesthesia within 4 weeks.

Design outcomes

Primary

Measure	Time frame
Sedation success rate;	—

Secondary

Measure	Time frame
Blood pressure;Heart rate;SpO2;	—

Countries

China

Contacts

Public ContactZhong Yu

The First Affiliated Hospital of Guangxi Medical University

zzlugl@163.com+86 151 7792 9679

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026